Associated British Foods plc - ASBFY

ASBFY Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
ASBFY	0.1	3.8	-7.9	-20.5	-24.8	-15.8	-16.2	-29.1	-47.4	177.7
S&P 500	1.0	3.7	2.1	2.3	8.2	25.4	31.0	80.6	196.5	33856.2

Compare ASBFY with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	ASBFY
name	Associated British Foods plc
price	24.58
changes percentage	0.0814
change	0.02
day low	24.56
day high	24.6
year high	35.26
year low	23.6
market cap	17806860804
price avg 50	27.1832
price avg 200	30.5567
exchange	PNK
volume	200
avg volume	20370
open	24.6
previous close	24.56
eps	2.37
pe	10.37
earnings announcement	2025-04-21T10:00:00.000+0000
shares outstanding	724445110
timestamp	2025-01-17 20:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 68.0%

Overall Quarterly Financial Health: 72.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
revenue	20073000000	19750000000	1.64
gross profit	4882000000	4163000000	17.27
gross profit ratio	0.24	0.21	15.38
research and development expenses	58000000	51000000	13.73
operating expenses	2950000000	2780000000	6.12
interest income	277000000	233000000	18.88
interest expense	266000000	250000000	6.40
ebitda	3132000000	2476000000	26.49
ebitdaratio	0.16	0.13	24.46
operating income	1932000000	1383000000	39.70
operating income ratio	0.1	0.07	37.45
net income	1455000000	1044000000	39.37
net income ratio	0.07	0.05	37.13
eps	1.94	1.34	44.78

Overall Score of Annual Income Statement

0.88 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 20,073 million in 2024 from 19,750 million in 2023 representing a change of 1.64%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 4,882 million in 2024 from 4,163 million in 2023 representing a change of 17.27%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 58 million in 2024 from 51 million in 2023 representing a change of 13.73%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 3,132 million in 2024 from 2,476 million in 2023 representing a change of 26.49%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 1,932 million in 2024 from 1,383 million in 2023 representing a change of 39.7%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 1,455 million in 2024 from 1,044 million in 2023 representing a change of 39.37%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.94 in 2024 from 1.94 in 2023 representing a change of 44.78%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 2,950 million in 2024 from 2,780 million in 2023 representing a change of 6.12%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q2	Q/Q change %
0000000000
revenue	10339000000	9734000000	6.22
gross profit	956000000	880000000	8.64
gross profit ratio	0.09	0.09	2.28
research and development expenses	58000000	0	NaN
operating expenses	-45000000	-51000000	11.76
interest income	0	70000000	-100.00
interest expense	0	124000000	-100.00
ebitda	1379000000	1185000000	16.37
ebitdaratio	0.13	0.12	9.56
operating income	1001000000	931000000	7.52
operating income ratio	0.1	0.1	1.23
net income	792000000	663000000	19.46
net income ratio	0.08	0.07	12.47
eps	1.06	0.87	21.84

Overall Score of Quarterly Income Statement

0.75 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 10,339 million in 2024Q4 from 9,734 million in 2024Q2 representing a change of 6.22%. This indicates a sales shrinking, which is a negative sign for the company.

  Operating Income: Operating income decreased to 1,001 million in 2024Q4 from 931 million in 2024Q2 representing a change of 7.52%. The decrease in operating income indicates worse operational performance and decreased profitability.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 956 million in 2024Q4 from 880 million in 2024Q2 representing a change of 8.64%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 58 million in 2024Q4 from 0 million in 2024Q2 representing a change of nan%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to -45 million in 2024Q4 from -51 million in 2024Q2 representing a change of 11.76%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 1,379 million in 2024Q4 from 1,185 million in 2024Q2 representing a change of 16.37%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 792 million in 2024Q4 from 663 million in 2024Q2 representing a change of 19.46%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.06 in 2024Q4 from 1.06 in 2024Q2 representing a change of 21.84%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
total assets	19014000000	18844000000	0.90
total liabilities	7736000000	7651000000	1.11
total equity	11278000000	11193000000	0.76
cash and cash equivalents	1323000000	1457000000	-9.20
short term investments	334000000	4000000	8250.00
long term investments	77000000	426000000	-81.92
total current assets	6520000000	6739000000	-3.25
total non current assets	12494000000	12105000000	3.21
total current liabilities	3668000000	3689000000	-0.57
total non current liabilities	4068000000	3962000000	2.68
common stock	42000000	44000000	-4.55
retained earnings	11395000000	10910000000	4.45
total debt	3678000000	3722000000	-1.18

Overall Score of Annual Balance Sheet

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 19,014 million in 2024 from 18,844 million in 2023 representing a change of 0.9%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 11,278 million in 2024 from 11,193 million in 2023 representing a change of 0.76%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 334 million in 2024 from 4 million in 2023 representing a change of 8250.0%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 3,668 million in 2024 from 3,689 million in 2023 representing a change of -0.57%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 11,395 million in 2024 from 10,910 million in 2023 representing a change of 4.45%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 3,678 million in 2024 from 3,722 million in 2023 representing a change of -1.18%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 7,736 million in 2024 from 7,651 million in 2023 representing a change of 1.11%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 1,323 million in 2024 from 1,457 million in 2023 representing a change of -9.2%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 6,520 million in 2024 from 6,739 million in 2023 representing a change of -3.25%. This indicates a worsen liquidity position.

  Common Stock: Common Stock decreased to 42 in 2024 from 44 in 2023 representing a change of -4.55%. This indicates a decrease in ownership interest.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q2	Q/Q change %
0000000000
total assets	19014000000	18741000000	1.46
total liabilities	7736000000	7576000000	2.11
total equity	11278000000	11165000000	1.01
cash and cash equivalents	1323000000	1268000000	4.34
short term investments	334000000	70000000	377.14
long term investments	77000000	396000000	-80.56
total current assets	6520000000	6349000000	2.69
total non current assets	12494000000	12392000000	0.82
total current liabilities	3668000000	3539000000	3.65
total non current liabilities	4068000000	4037000000	0.77
common stock	42000000	43000000	-2.33
retained earnings	11395000000	11043000000	3.19
total debt	3678000000	3764000000	-2.28

Overall Score of Quarterly Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 19,014 million in 2024Q4 from 18,741 million in 2024Q2 representing a change of 1.46%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 11,278 million in 2024Q4 from 11,165 million in 2024Q2 representing a change of 1.01%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,323 million in 2024Q4 from 1,268 million in 2024Q2 representing a change of 4.34%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 334 million in 2024Q4 from 70 million in 2024Q2 representing a change of 377.14%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 6,520 million in 2024Q4 from 6,349 million in 2024Q2 representing a change of 2.69%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 11,395 million in 2024Q4 from 11,043 million in 2024Q2 representing a change of 3.19%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 3,678 million in 2024Q4 from 3,764 million in 2024Q2 representing a change of -2.28%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 7,736 million in 2024Q4 from 7,576 million in 2024Q2 representing a change of 2.11%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 3,668 million in 2024Q4 from 3,539 million in 2024Q2 representing a change of 3.65%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 42 in 2024Q4 from 43 in 2024Q2 representing a change of -2.33%. This indicates a decrease in ownership interest.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024	2023	Y/Y change %
0000000000
net change in cash	-153000000	-607000000	74.79
operating cash flow	2874000000	1654000000	73.76
free cash flow	1690000000	581000000	190.88
capital expenditure	-1184000000	-1073000000	-10.34
depreciation and amortization	949000000	886000000	7.11
deferred income tax	0	-389000000	100.00
stock based compensation	31000000	18000000	72.22
accounts payables	0	-15000000	100.00
inventory	170000000	-103000000	265.05
acquisitions net	-69000000	-90000000	23.33
investments in property plant and equipment	-1124000000	-997000000	-12.74
net cash used for investing activites	-1332000000	-906000000	-47.02
debt repayment	16000000	-308000000	105.19
common stock issued	0	0	NaN
common stock repurchased	-582000000	-494000000	-17.81
dividends paid	-502000000	-345000000	-45.51
net cash used provided by financing activities	-1569000000	-1282000000	-22.39
cash at end of period	1235000000	1388000000	-11.02
accounts receivables	23000000	-107000000	121.50
cash at beginning of period	1388000000	1995000000	-30.43

Overall Score of Annual Cashflow Statement

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -153 million in 2024 from -607 million in 2023 representing a change of 74.79%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 2,874 million in 2024 from 1,654 million in 2023 representing a change of 73.76%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 1,690 million in 2024 from 581 million in 2023 representing a change of 190.88%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -1,184 million in 2024 from -1,073 million in 2023 representing a change of -10.34%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2024 from 15 million in 2023 representing a change of 100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2024 from -389 million in 2023 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 31 million in 2024 from 18 million in 2023 representing a change of 72.22%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 23 in 2024 from -107 million in 2023 representing a change of 121.5%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -502 million in 2024 from -345 million in 2023 representing a change of -45.51%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q4	2024Q2	Q/Q change %
0000000000
operating cash flow	1698000000	1176000000	44.39
free cash flow	1097000000	653000000	67.99
capital expenditure	-601000000	-523000000	-14.91
depreciation and amortization	505000000	444000000	13.74
deferred income tax	0	0	NaN
stock based compensation	18000000	13000000	38.46
accounts receivables	-34000000	57000000	-159.65
accounts payables	0	0	NaN
inventory	122000000	47000000	159.57
acquisitions net	-89000000	-4000000	-2125.00
investments in property plant and equipment	-601000000	-523000000	-14.91
net cash used for investing activites	-854000000	-478000000	-78.66
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-298000000	-284000000	-4.93
dividends paid	-154000000	-348000000	55.75
net cash used provided by financing activities	-762000000	-807000000	5.58
net change in cash	-1209000000	-189000000	-539.68
cash at end of period	0	1268000000	-100.00
cash at beginning of period	1209000000	1457000000	-17.02

Overall Score of Quarterly Cashflow Statement

0.71 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -1,209 million in 2024Q4 from -189 million in 2024Q2 representing a change of -539.68%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Stock-Based Compensation: Stock-Based Compensation increased to 18 million in 2024Q4 from 13 million in 2024Q2 representing a change of 38.46%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 1,698 million in 2024Q4 from 1,176 million in 2024Q2 representing a change of 44.39%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 1,097 million in 2024Q4 from 653 million in 2024Q2 representing a change of 67.99%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -601 million in 2024Q4 from -523 million in 2024Q2 representing a change of -14.91%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Accounts Receivables: Accounts Receivables decreased to -34 million in 2024Q4 from 57 million in 2024Q2 representing a change of -159.65%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -154 million in 2024Q4 from -348 million in 2024Q2 representing a change of 55.75%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q4 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q2 2023 Earnings call transcript
Q4 2022 Earnings call transcript
Q1 2022 Earnings call transcript
Q4 2021 Earnings call transcript
Q2 2021 Earnings call transcript
Q2 2018 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2024-09-30	2023-09-30	Y/Y change %
FY
calendar year	2024	2023	NaN
revenue per share	26.73	25.4	5.22
net income per share	1.94	1.34	44.38
operating cash flow per share	3.87	2.17	78.70
free cash flow per share	2.38	0.79	201.34
cash per share	2.21	1.88	17.49
book value per share	15.02	14.39	4.38
tangible book value per share	12.49	10.36	20.63
shareholders equity per share	14.89	14.26	4.46
interest debt per share	5.08	4.95	2.60
market cap	17520830000	16089040000	8.90
enterprise value	19875830000	18354040000	8.29
pe ratio	12.04	15.41	-21.86
price to sales ratio	0.87	0.81	7.22
pocfratio	6.02	9.54	-36.87
pfcf ratio	9.81	26.2	-62.56
pb ratio	1.57	1.45	7.99
ptb ratio	1.57	1.45	7.99
ev to sales	0.99	0.93	6.62
enterprise value over ebitda	6.35	8.23	-22.90
ev to operating cash flow	6.83	10.88	-37.22
ev to free cash flow	11.13	29.89	-62.77
earnings yield	0.08	0.06	27.98
free cash flow yield	0.1	0.04	167.11
debt to equity	0.33	0.34	-2.00
debt to assets	0.19	0.2	-2.07
net debt to ebitda	0.75	1.02	-25.97
current ratio	1.78	1.83	-2.70
interest coverage	14.31	11.77	21.55
income quality	2	1.62	23.77
dividend yield	0.03	0.02	33.62
payout ratio	0.35	0.33	4.41
sales general and administrative to revenue	0.07	0.06	10.24
research and ddevelopement to revenue	0	0.0	-100.00
intangibles to total assets	0.1	0.17	-40.08
capex to operating cash flow	0.39	0.64	-39.27
capex to revenue	0.06	0.05	3.14
capex to depreciation	1.18	1.21	-2.20
stock based compensation to revenue	0.0	0.0	69.56
graham number	25.48	20.75	22.81
roic	0.09	0.07	26.57
return on tangible assets	0.08	0.07	27.89
graham net net	-4.28	-4.02	-6.40
working capital	2852000000	3050000000	-6.49
tangible asset value	9382000000	8057000000	16.45
net current asset value	-1216000000	-912000000	-33.33
invested capital	13101000000	14302000000	-8.40
average receivables	1839500000	1597500000	15.15
average payables	2055500000	1269500000	61.91
average inventory	3171000000	3335000000	-4.92
days sales outstanding	32.71	34.72	-5.79
days payables outstanding	70.5	27.8	153.61
days of inventory on hand	72.95	78.08	-6.57
receivables turnover	11.16	10.51	6.14
payables turnover	5.18	13.13	-60.57
inventory turnover	5.0	4.67	7.03
roe	0.13	0.09	38.21
capex per share	1.5	1.38	8.52

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 12.04 on 2024-09-30 from 15.41 on 2023-09-30, representing a change of -21.86%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.78 on 2024-09-30 from 1.83 on 2023-09-30, representing a change of -2.70%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.33 on 2024-09-30 from 0.34 on 2023-09-30, representing a change of -2.00%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q4	2024-02-29 Q2	Q/Q change %
ASBFY
calendar year	2024	2024	NaN
revenue per share	13.9	12.84	8.21
net income per share	1.06	0.87	21.70
operating cash flow per share	2.31	1.55	49.01
free cash flow per share	1.5	0.86	74.58
cash per share	2.23	1.67	33.14
book value per share	15.16	14.73	2.91
tangible book value per share	12.61	12.24	3.00
shareholders equity per share	15.03	14.61	2.87
interest debt per share	5.04	5.05	-0.12
market cap	17357782999.09	17229343636.8	0.75
enterprise value	19712782999.09	19725343636.8	-0.06
pe ratio	5.48	6.5	-15.66
price to sales ratio	1.68	1.77	-5.15
pocfratio	10.09	14.65	-31.12
pfcf ratio	15.51	26.38	-41.21
pb ratio	1.55	1.56	-0.23
ptb ratio	1.55	1.56	-0.23
ev to sales	1.91	2.03	-5.91
enterprise value over ebitda	12.69	16.65	-23.74
ev to operating cash flow	11.46	16.77	-31.67
ev to free cash flow	17.62	30.21	-41.68
earnings yield	0.05	0.04	18.57
free cash flow yield	0.06	0.04	70.09
debt to equity	0.33	0.34	-3.23
debt to assets	0.19	0.2	-3.69
net debt to ebitda	1.52	2.11	-28.01
current ratio	1.78	1.79	-0.92
interest coverage	13.15	15.02	-12.42
income quality	2.17	1.77	22.44
dividend yield	0.01	0.02	-56.07
payout ratio	0.19	0.52	-62.95
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.1	0.1	-0.86
capex to operating cash flow	0.35	0.44	-21.43
capex to revenue	0.06	0.05	8.19
capex to depreciation	1.19	1.18	1.03
stock based compensation to revenue	0	0.0	-100.00
graham number	18.98	16.96	11.89
roic	0.05	0.05	1.23
return on tangible assets	0.05	0.04	17.63
graham net net	-4.32	-4.52	4.50
working capital	2852000000	2810000000	1.49
tangible asset value	9382000000	9280000000	1.10
net current asset value	-1216000000	-1227000000	0.90
invested capital	13101000000	13004000000	0.75
average receivables	1738000000	1778500000	-2.28
average payables	2866500000	1988000000	44.19
average inventory	3142000000	3277000000	-4.12
days sales outstanding	15.66	15.51	1.00
days payables outstanding	28.15	28.45	-1.04
days of inventory on hand	29.13	33.02	-11.76
receivables turnover	5.75	5.8	-0.99
payables turnover	3.2	3.16	1.06
inventory turnover	3.09	2.73	13.33
roe	0.07	0.06	18.30
capex per share	0.81	0.69	17.07

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 5.48 on 2024-09-30 Q4 from 6.50 on 2024-02-29 Q2, representing a change of -15.66%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.78 on 2024-09-30 Q4 from 1.79 on 2024-02-29 Q2, representing a change of -0.92%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.33 on 2024-09-30 Q4 from 0.34 on 2024-02-29 Q2, representing a change of -3.23%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 31.11 which is higher than current price 24.58, indicates the company may be undervalued.